{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:03:04Z","timestamp":1761901384912,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.msard.2018.03.016","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T23:15:59Z","timestamp":1525130159000},"page":"A1-A2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Editors\u2019 Welcome"],"prefix":"10.1016","volume":"21","author":[{"given":"Michael","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin","family":"Giovannoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Hawkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Waubant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.03.016_bib1","unstructured":"Biogen, 2017. TYSABRI\u00ae (natalizumab): PML Incidence in Patients Receiving TYSABRI. Biogen."},{"issue":"4","key":"10.1016\/j.msard.2018.03.016_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729901","article-title":"Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review","volume":"24","author":"Bohra","year":"2017","journal-title":"Cancer Control"},{"issue":"7","key":"10.1016\/j.msard.2018.03.016_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/1352458512471880","article-title":"Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis","volume":"19","author":"Cree","year":"2013","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.msard.2018.03.016_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00415-017-8509-9","article-title":"Progressive multifocal leukoencephalopathy in patients treated with fumaric acid esters: a review of 19 cases","volume":"264","author":"Gieselbach","year":"2017","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.msard.2018.03.016_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(17)30282-X","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies","volume":"16","author":"Ho","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2018.03.016_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.msard.2018.02.008","article-title":"Humoral response to John Cunningham virus during pregnancy in multiple sclerosis","volume":"21","author":"Saraste","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.msard.2018.03.016_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/aji.12355","article-title":"Viral infections during pregnancy","volume":"73","author":"Silasi","year":"2015","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.msard.2018.03.016_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0b013e318225ab3f","article-title":"Progressive multifocal leukoencephalopathy in a patient without immunodeficiency","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.03.016_bib9","first-page":"819216","article-title":"What do healthcare providers advise women with multiple sclerosis regarding pregnancy?","volume":"2014","author":"Wundes","year":"2014","journal-title":"Mult Scler Int"},{"issue":"3","key":"10.1016\/j.msard.2018.03.016_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cen3.12397","article-title":"Neurological safety of fingolimod: An updated review","volume":"8","author":"Yoshii","year":"2017","journal-title":"Clin Exp Neuroimmunol"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818301032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818301032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:42:21Z","timestamp":1761900141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818301032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":10,"alternative-id":["S2211034818301032"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.03.016","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editors\u2019 Welcome","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}